| EPHA3 | EPH receptor A3 |
| BLCA | bladder cancer |
| NMIBC | non-muscle-invasive bladder cancer |
| MIBC | muscle-invasive bladder cancer |
| TCGA | The Cancer Genome Atlas |
| ROC | receiver operating characteristic |
| GEO | Gene Expression Omnibus |
| ICG | immune checkpoint gene |
| ICI | immune checkpoint inhibitor |
| TIDE | tumor immune dysfunction and exclusion |
| OS | overall survival |
| AUC | area under ROC |
| pERK1/2 | phosphorylation-ERK 1/2 |
| ESTIMATE | Estimation of STromal and Immune cells in Malignant Tumor tissues |
| TIMER | Tumor Immune Estimation Resource |
| RTKs | Receptor tyrosine-kinases |
| GO | Gene Ontology |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| PPI | protein–protein interaction |
| PI | propidium iodide |
| CCK8 | counting kit-8 |
| RT-qPCR | real-time quantitative PCR |
| MCP-counter | microenvironment cell populations-counter |